LAKE FOREST, Ill., Jan. 5 /PRNewswire-FirstCall/ -- Hospira, Inc. , one of the largest hospital products manufacturers in the United States, today announced that Terrence C. Kearney, senior vice president, Finance, and chief financial officer, will make a formal presentation at the JPMorgan 24th Annual Healthcare Conference on Tuesday, Jan. 10, 2006, at The Westin St. Francis Hotel in San Francisco.
The presentation will be open to all interested parties at noon Eastern Time on Tuesday, Jan. 10, 2006, through a live audiocast in the investor relations section of Hospira’s Web site, www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. A replay will be available on the Hospira Web site approximately 24 hours after the live presentation until Jan. 17. In addition, the slides accompanying the presentation will be available on the Hospira Web site, beginning at 11:45 a.m.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the productivity, safety and efficacy of patient care. With 70 years of service to the hospital industry, Hospira’s portfolio includes one of the industry’s broadest lines of generic acute-care injectables, which help address the high cost of proprietary pharmaceuticals; integrated solutions for medication management and infusion therapy; and the leading U.S. injectable contract manufacturing business. Headquartered in Lake Forest, Ill., north of Chicago, Hospira has approximately 13,000 employees and 14 manufacturing facilities worldwide. Hospira’s news releases and other information can be found at www.hospira.com.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comHospira, Inc.
CONTACT: Media, Stacey Eisen, +1-224-212-2276, or Financial Community,Lynn McHugh, +1-224-212-2363, both of Hospira
Web site: http://www.hospira.com/
